Thiogenesis Therapeutics Corp TTIPF
$0.42
Last Updated: Aug 07, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
TTIPF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Thiogenesis Therapeutics Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Thiogenesis Therapeutics Corp. Stock Analysis TTIPF
United States N/A Nano Cap Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-07-16. The firm is developing sulfur-containing prodrugs that act as precursors with the potential to treat serious pediatric diseases with unmet medical needs. Its lead compound, TTI-0102, is a disulfide, made up of two thiols that lead to two independent cysteamine molecules. Cysteamine is a thiol that has been rigorously studied and tested. TTI-0102 has been developed to address the obstacles facing previous thiol-based drugs, their short half-lives and side effects. As a prodrug, TTI-0102 is metabolized into cysteamine molecules after it is ingested. The metabolic process acts as a gating mechanism that eliminates the spike in the immediate release of cysteamine that is commonly linked to GI side effects. TTI-0102’s initial applications are for mitochondrial encephalopathy, lactic acidosis and stroke-like episodes, Leigh syndrome, Rett syndrome and pediatric Nonalcoholic steatohepatitis.
Thiogenesis Therapeutics Corp (TTIPF) Chart
Financial Metrics & Statements of Thiogenesis Therapeutics Corp (TTIPF)
FAQ's for Thiogenesis Therapeutics Corp (TTIPF)
- As of August 2026, Thiogenesis Therapeutics Corp TTIPF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Thiogenesis Therapeutics Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Thiogenesis Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Thiogenesis Therapeutics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Thiogenesis Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Thiogenesis Therapeutics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Thiogenesis Therapeutics Corp (TTIPF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
